23rd International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents

摘要 卡波西肉瘤疱疹病毒和相关因子的年度国际会议将 将研究致癌人类疱疹病毒的研究人员和临床医生聚集在一起， 卡波西肉瘤疱疹病毒（KSHV）和其他密切相关的病原体。KSHV是 卡波西肉瘤（KS）的病原体，这仍然是最常见的癌症之一， 非洲，尤其是HIV-1感染者。这些会议的目标是一致的， NIH、NCI、NIAID和NIDCR的使命声明，即推进和促进 对与人类癌症和其他疾病有关的感染的研究步伐，包括 in the setting设置of HIV-AIDS艾滋病.主要的KSHV会议将在坦桑尼亚达累斯萨拉姆举行， 从2023年6月19日下午到6月22日另外一天，6月23日， 举办培训讲习班，让知名研究人员和受训人员、临床医生和基础 研究人员，互动和发展合作的转化研究项目。的 会议的大部分费用将来自大会支付的注册费。 会议与会者和来自主办机构，基金会和制药公司的捐款 和生物技术公司。KSHV会议的主要焦点是生物学， 致癌疱疹病毒和相关的人类疾病，特别强调病毒 致病机理，病毒潜伏和再激活，病毒基因表达和复制，宿主 感染反应、流行病学、疫苗开发、治疗干预、临床 和翻译研究。除了KSHV，与松鼠猴疱疹病毒（HVS）相关的研究， 鼠疱疹病毒-68（MHV-68）和恒河猴鼻状病毒（RRV）。这 行政补助金申请要求资金补充R13奖 （7 R13 CA 250288）收到的会议应于2020年举行。的 延迟至二零二三年的原因是由于COVID-19。补充是必要的，因为 奖励金额（5，000美元）将需要支付计划的通货膨胀成本 注册费不能支付的会议场地。所要求的补充 资金将用于减少会议登记费和部分差旅费， 博士前和博士后学员，历史上代表性不足的少数民族，以及来自 低收入和中等收入国家，特别是那些研究致癌DNA的非洲国家， 病毒和与这些病毒相关的癌症。

ABSTRACT The annual International Conference on Kaposi’s Sarcoma Herpesvirus and Related Agents will bring together researchers and clinicians working on the oncogenic human herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV), and other closely related pathogens. KSHV is the etiology agent of Kaposi’s sarcoma (KS), which is still one of the most prevalent cancers in Africa, especially in HIV-1 infected individuals. The goals of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to advance and promote the pace of research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The main KSHV conference will be held in Dar es Salaam, Tanzania, from the afternoon of June 19 through June 22, 2023. With an additional day, June 23, for a training workshop to engage both established researchers and trainees, clinicians and basic researchers, to interact and develop collaborations on translational research projects. The majority of the costs for the conference will be raised from registration fees paid by the conference attendees and contributions from host institutions, foundations, and pharmaceutical and biotechnology companies. The major focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, therapeutic intervention, clinical and translational research. In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. This administrative supplement grant application requests funds to supplement the R13 award (7R13CA250288) received for the conference which was supposed to be held in 2020. The reason for the delay to 2023 was due to COVID-19. The supplement is needed because of the awarded amount ($5,000) will be needed to cover the rising inflation cost of the planned conference site which cannot be covered by the registration fees. The requested supplement funds will be used to reduce the conference registration and partial travel costs for outstanding pre- and post-doctoral trainees, historically under-represented minorities, and scientists from lower- and middle-income countries, especially those from Africa who study oncogenic DNA viruses and the cancers associating with these viruses.